Inzen Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 37

Employees

  • Latest Deal Type
  • M&A

Inzen General Information

Description

Operator of a biotechnology company intended to develop drugs for the treatment of chronic diseases. The company's platform utilizes mass spectrometry and machine learning, novel probes, genetic and chemical biological technologies to develop novel products for the treatment of cancer, fibrotic disorders, immune-inflammatory disorders, metabolic disorders and degenerative diseases, enabling medical health practitioners to provide treatment for such diseases.

Contact Information

Website
www.inzentx.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 500 Arsenal Street
  • Watertown, MA 02472
  • United States
+1 (617)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Acquirer
Sonata Therapeutics
Vertical(s)
Big Data, Artificial Intelligence & Machine Learning, Life Sciences, Oncology
Corporate Office
  • 500 Arsenal Street
  • Watertown, MA 02472
  • United States
+1 (617)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Inzen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 18-May-2022 Completed Generating Revenue
1. Early Stage VC (Series A) 01-Jan-2018 Completed Generating Revenue
To view Inzen’s complete valuation and funding history, request access »

Inzen Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A1
Series A
To view Inzen’s complete cap table history, request access »

Inzen Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Inzen Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
ACS BrightEdge Corporate Venture Capital Minority
Flagship Pioneering Venture Capital Minority
To view Inzen’s complete investors history, request access »

Inzen Acquisitions (1)

Inzen’s most recent deal was a Merger of Equals with Sonata Therapeutics. The deal was made on 18-May-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Sonata Therapeutics 18-May-2022 Merger of Equals Drug Discovery
To view Inzen’s complete acquisitions history, request access »

Ready to get started?

Request a free trial

Inzen FAQs

  • When was Inzen founded?

    Inzen was founded in 2017.

  • Where is Inzen headquartered?

    Inzen is headquartered in Watertown, MA.

  • What is the size of Inzen?

    Inzen has 37 total employees.

  • What industry is Inzen in?

    Inzen’s primary industry is Drug Discovery.

  • Is Inzen a private or public company?

    Inzen is a Private company.

  • What is Inzen’s current revenue?

    The current revenue for Inzen is .

  • How much funding has Inzen raised over time?

    Inzen has raised $20M.

  • Who are Inzen’s investors?

    ACS BrightEdge and Flagship Pioneering have invested in Inzen.

  • When was Inzen acquired?

    Inzen was acquired on 18-May-2022.

  • Who acquired Inzen?

    Inzen was acquired by Sonata Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process